{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VTGN/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-14T23:54:01.235Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":749,"canonical_name":"Vistagen Therapeutics, Inc.","cik":"0001411685","uei":null,"lei":null,"duns":null,"ticker":"VTGN"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":28},"count":28,"timeline":[{"ts":"2026-10-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-10-09","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-065559","accession_number":"0001628280-26-065559","importance":35},{"ts":"2026-09-25","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-09-25","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-063510","accession_number":"0001628280-26-063510","importance":35},{"ts":"2026-09-24","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-09-24","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-063316","accession_number":"0001628280-26-063316","importance":35},{"ts":"2026-09-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-09-22","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-063046","accession_number":"0001628280-26-063046","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-061445","accession_number":"0001628280-26-061445","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Vistagen Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001411685/10-q/0001628280-26-057116","accession_number":"0001628280-26-057116","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-056953","accession_number":"0001628280-26-056953","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vistagen Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001411685/schedule-13g-a/0001193125-26-352371","accession_number":"0001193125-26-352371","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vistagen Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001411685/schedule-13g-a/0001831942-26-000032","accession_number":"0001831942-26-000032","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-054341","accession_number":"0001628280-26-054341","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-053304","accession_number":"0001628280-26-053304","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Vistagen Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001411685/def-14a/0001628280-26-051404","accession_number":"0001628280-26-051404","importance":40},{"ts":"2026-07-31","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-051251","accession_number":"0001628280-26-051251","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"3","title":"3 — Vistagen Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001411685/3/0001911501-26-000004","accession_number":"0001911501-26-000004","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"4","title":"4 — Vistagen Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001411685/4/0001911501-26-000006","accession_number":"0001911501-26-000006","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Vistagen Therapeutics, Inc. — 2026-07-31","url_slug":"/sec/cik-0001411685/defa14a/0001628280-26-051406","accession_number":"0001628280-26-051406","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Vistagen Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001411685/4/0001412071-26-000006","accession_number":"0001412071-26-000006","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-046143","accession_number":"0001628280-26-046143","importance":35},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Adler Reid G.","title":"Chief Legal Officer","shares":36818,"price_per_share":0.1921,"usd_value":7073,"security_title":"Common Stock","importance":15.0070727378},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Singh Shawn","title":"President and CEO","shares":36818,"price_per_share":0.1921,"usd_value":7073,"security_title":"Common Stock","importance":15.0070727378},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Tressler Nick B.","title":"Chief Financial Officer","shares":11712,"price_per_share":0.1921,"usd_value":2250,"security_title":"Common Stock","importance":15.0022498752},{"ts":"2026-06-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-043989","accession_number":"0001628280-26-043989","importance":35},{"ts":"2026-06-15","kind":"sec.filing","form_type":"10-K","title":"10-K — Vistagen Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001411685/10-k/0001628280-26-043271","accession_number":"0001628280-26-043271","importance":55},{"ts":"2026-06-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-043232","accession_number":"0001628280-26-043232","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-041962","accession_number":"0001628280-26-041962","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vistagen Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001411685/schedule-13g-a/0001193125-26-226886","accession_number":"0001193125-26-226886","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-033883","accession_number":"0001628280-26-033883","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Vistagen Therapeutics, Inc. — 2026-05-08","url_slug":"/sec/cik-0001411685/8-k/0001628280-26-032935","accession_number":"0001628280-26-032935","importance":35}]}